Company Filing History:
Years Active: 2022-2024
Title: Innovations of Nate Hathaway
Introduction
Nate Hathaway is an accomplished inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of chemical epigenetics, holding two patents that showcase his innovative work. His research focuses on developing novel compounds and methods that have the potential to impact various medical conditions.
Latest Patents
Hathaway's latest patents include "Bifunctional Chemical Epigenetic Modifiers and Methods of Use" and "Heterochromatin Gene Repression Inhibitors." The first patent relates to bifunctional chemical epigenetic modifiers, which can include a FK506 molecule or its derivatives, a linker, and a bifunctional ligand, such as a histone deacetylase inhibitor. The second patent involves chemical compounds that inhibit HP1-mediated heterochromatin formation, along with pharmaceutical compositions containing these compounds. These inventions aim to address disorders related to heterochromatin formation, including cancer.
Career Highlights
Nate Hathaway is affiliated with the University of North Carolina at Chapel Hill, where he conducts his research and development. His work has garnered attention for its potential applications in treating various disorders, showcasing his commitment to advancing scientific knowledge and therapeutic options.
Collaborations
Hathaway collaborates with notable colleagues, including Jian Jin and Kyle Butler, who contribute to his research endeavors. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Nate Hathaway's contributions to the field of chemical epigenetics through his patents reflect his dedication to innovation and research. His work has the potential to lead to significant advancements in medical treatments and understanding of genetic mechanisms.